leisure time -WSS

leisure time

author：hotspot 2025-10-03 00:07:04 - browse：8

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

focus

WSS

The problem with charging patients to message their doctors

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

In his State of the Union, Biden takes clear aim at 'Big Pharma'

2 officers injured in shooting in Orlando, police say

The a glaring gap in research on serious mental illness and primary care

NEJM study link tiny plastics in blood vessels to heart problems

knowledge

leisure time

explore

Moonlake's readout produced a cash windfall. Risks remain

Study links childhood stress with decline in older age

Malaria cases in Florida and Texas: Here’s what you need to know

The a glaring gap in research on serious mental illness and primary care

Dobbs anniversary: the lost opportunity of abortion as health care

IVF, abortion rights issues kick off Biden’s State of the Union

Guidelines to prevent youth baseball injuries need more muscle

'Null' research findings aren't empty of meaning. Let's publish them

Tori Bowie and the unacceptable rates of Black maternal death

The a glaring gap in research on serious mental illness and primary care

entertainment

Just how do doctors, lawmakers, and the public define abortion?

Chris Christie meets with Zelenskyy during Ukraine trip

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Former medical device CEO who sold dummy, plastic parts convicted of fraud

H.R. 3 is the wrong path to lower drug costs

Amylyx ALS drug failure raises questions and concerns

focus

leisure time

focus

entertainment